Secondary prophylaxis of hepatic encephalopathy in cirrhosis: A double blind randomized controlled trial of L-ornithine L-aspartate versus placebo

被引：0
|
作者：
Varakanahalli, S. [1 ]
Sharma, B. [1 ]
Sachdeva, S. [1 ]
Dahale, A. [1 ]
Srivastava, S. [1 ]
机构：
[1] GB Pant Inst Postgrad Med Educ & Res, Gastroenterol, New Delhi, India
来源：
JOURNAL OF HEPATOLOGY | 2018年 / 68卷
关键词：
D O I：
10.1016/S0168-8278(18)30304-0
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
PS-074
引用
收藏
页码：S43 / S43
页数：1
相关论文
共 50 条
  • [1] Secondary prophylaxis of hepatic encephalopathy in cirrhosis of liver: a double-blind randomized controlled trial of L-ornithine L-aspartate versus placebo
    Varakanahalli, Shivakumar
    Sharma, Barjesh C.
    Srivastava, Siddharth
    Sachdeva, Sanjeev
    Dahale, Amol S.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2018, 30 (08) : 951 - 958
  • [2] L-ornithine L-aspartate in acute treatment of severe hepatic encephalopathy: A double-blind randomized controlled trial
    Jain, Arpan
    Sharma, Barjesh Chander
    Mahajan, Bhawna
    Srivastava, Siddharth
    Kumar, Ajay
    Sachdeva, Sanjeev
    Sonika, Ujjwal
    Dalal, Ashok
    HEPATOLOGY, 2022, 75 (05) : 1194 - 1203
  • [3] Letter to the editor: L-ornithine L-aspartate in acute treatment of severe hepatic encephalopathy: A double-blind randomized controlled trial
    Kovalic, Alexander J.
    Lee, Tai-Ping
    Da, Ben L.
    HEPATOLOGY, 2022, 76 (05) : E108 - E109
  • [4] A randomized, double-blind, clinical trial comparing lactulose, l-ornithine l-aspartate, or rifaximin, versus placebo, as primary prophylaxis of hepatic encephalopathy in cirrhotic patients with variceal bleeding
    de La Tijera, F. H.
    Servin-Caamano, A. I.
    Abdo-Francis, J. M.
    Salas-Gordillo, F.
    Perez-Hernandez, J. L.
    Camacho-Aguilera, J.
    Alla, S. N.
    Jimenez-Ponce, F.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S49 - S49
  • [5] Effect of Rifaximin, Probiotics, and l-Ornithine l-Aspartate on Minimal Hepatic Encephalopathy: A Randomized Controlled Trial
    Sharma, Kapil
    Pant, Sanjay
    Misra, Sriprakash
    Dwivedi, Manisha
    Misra, Alok
    Narang, Sushil
    Tewari, Reshu
    Bhadoria, Ajeet S.
    SAUDI JOURNAL OF GASTROENTEROLOGY, 2014, 20 (04): : 225 - 232
  • [6] L-Ornithine L-Aspartate is Effective and Safe for the Treatment of Hepatic Encephalopathy in Cirrhosis
    Sidhu, Sandeep S.
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2018, 8 (03) : 219 - 221
  • [7] L-ornithine L-aspartate for prevention and treatment of hepatic encephalopathy in people with cirrhosis
    Goh, Ee Teng
    Stokes, Caroline S.
    Sidhu, Sandeep S.
    Vilstrup, Hendrik
    Gluud, Lise Lotte
    Morgan, Marsha Y.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2018, (05):
  • [8] l-Ornithine l-Aspartate (LOLA) for Hepatic Encephalopathy in Cirrhosis: Results of Randomized Controlled Trials and Meta-Analyses
    Roger F. Butterworth
    Mark J. W. McPhail
    Drugs, 2019, 79 : 31 - 37
  • [9] A randomized controlled trial comparing lactulose, probiotics, and L-ornithine L-aspartate in treatment of minimal hepatic encephalopathy
    Mittal, Vibhu Vibhas
    Sharma, Barjesh Chander
    Sharma, Praveen
    Sarin, Shiv Kumar
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2011, 23 (08) : 725 - 732
  • [10] L-Ornithine L-Aspartate (LOLA) for Hepatic Encephalopathy in Cirrhosis: Results of Randomized Controlled Trials and Meta-Analyses
    Butterworth, Roger F.
    McPhail, Mark J. W.
    DRUGS, 2019, 79 (Suppl 1) : 31 - 37
12345